心力衰竭患者的评估。

Evaluation of patients with heart failure.

机构信息

Division of Cardiovascular Medicine, University of Minnesota Medical Center, Lillehei Heart Institute, University of Minnesota, 420 Delaware Street Southeast, MMC 508, Minneapolis, MN 55455, USA.

出版信息

Cardiol Clin. 2014 Feb;32(1):47-62, viii. doi: 10.1016/j.ccl.2013.09.014.

DOI:10.1016/j.ccl.2013.09.014

PMID:24286578

Abstract

Heart failure is one of the most prevalent cardiovascular diseases in the United States, and is associated with significant morbidity, mortality, and costs. Prompt diagnosis may help decrease mortality, hospital stay, and costs related to treatment. A complete heart failure evaluation comprises a comprehensive history and physical examination, echocardiogram, and diagnostic tools that provide information regarding the etiology of heart failure, related complications, and prognosis in order to prescribe appropriate therapy, monitor response to therapy, and transition expeditiously to advanced therapies when needed. Emerging technologies and biomarkers may provide better risk stratification and more accurate determination of cause and progression.

摘要

心力衰竭是美国最常见的心血管疾病之一，与显著的发病率、死亡率和医疗费用相关。及时诊断可能有助于降低死亡率、住院时间和与治疗相关的费用。全面的心力衰竭评估包括全面的病史和体格检查、超声心动图以及提供心力衰竭病因、相关并发症和预后信息的诊断工具，以便开出适当的治疗方案、监测治疗反应，并在需要时迅速过渡到高级治疗。新兴技术和生物标志物可能提供更好的风险分层和更准确的病因和进展判断。